Compound Detail
CHEMBL292028
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL292028 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HIBJOZRCQRZAPY-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
283.7
MW (Da)
2.92
ALogP
5
HBA
0
HBD
55.3
PSA (Ų)
0.85
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 6.5
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MT4 CHEMBL388 | EC50 | 6.5 | 6.5 | 320.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MT4 | EC50 | = | 320.0 | nM | 6.5 | Compound was evaluated for the inhibition of HIV-1 induced CPE (HTLV-III B strai... | 7540208 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7540208 | 10.1021/jm00012a002 | MT4 | 2 |
| 7540208 | 10.1021/jm00012a002 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine